SAN DIEGO, DECEMBER 22, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES SIGNING OF DEFINITIVE MERGER AGREEMENT WITH ADAMIS PHARMACEUTICALS

SAN DIEGO, DECEMBER 7, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES SIGNING OF DEFINITIVE MERGER AGREEMENT WITH ADAMIS PHARMACEUTICALS

SAN DIEGO, NOVEMBER 25, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES THE ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

SAN DIEGO, NOVEMBER 16, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES THE ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

SAN DIEGO, NOVEMBER 9, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES THE ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS

SAN DIEGO, NOVEMBER 2, 2009
LA JOLLA PHARMACEUTICAL COMPANY REPORTS THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

SAN DIEGO, OCTOBER 14, 2009
LA JOLLA PHARMACEUTICAL COMPANY TO SEEK STOCKHOLDER APPROVAL OF DISSOLUTION

SAN DIEGO, SEPTEMBER 18, 2009
LA JOLLA PHARMACEUTICAL COMPANY RECEIVES NOTICE OF NONCOMPLIANCE WITH NASDAQ STOCK MARKET LISTING REQUIREMENT

SAN DIEGO, APRIL 8, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES GOING CONCERN OPINION AND RECEIPT OF NASDAQ STAFF DEFICIENCY LETTER

SAN DIEGO, FEBRUARY 19, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES REDUCTION IN WORKFORCE AND EVALUATES STRATEGIC OPTIONS

SAN DIEGO, FEBRUARY 11, 2009
LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES NEGATIVE RESULTS OF INTERIM EFFICACY ANALYSIS FOR RIQUENT PHASE 3 ASPEN TRIAL

SAN DIEGO, FEBRUARY 5, 2009
LA JOLLA PHARMACEUTICAL COMPANY TO PRESENT AT BIO CEO & INVESTOR CONFERENCE

SAN DIEGO, JANUARY 7, 2009
BIOMARIN AND LA JOLLA PHARMACEUTICAL SIGN WORLDWIDE (EXCLUDING ASIA PACIFIC) DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR RIQUENT